Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Bright Minds Biosciences Inc. (DRUG) had Debt to Equity Ratio of 0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.73M |
|
-- |
|
-- |
|
$8.26M |
|
$-8.26M |
|
$6.53M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-8.26M |
|
$-8.25M |
|
9.83M |
|
9.83M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$224.12M |
|
-- |
|
$0.04M |
|
$224.16M |
|
$1.84M |
|
-- |
|
-- |
|
$1.84M |
|
$222.32M |
|
$222.32M |
|
$222.32M |
|
9.86M |
|
| Cash Flow Statement Financials | |
$-16.90M |
|
-- |
|
$174.75M |
|
$59.88M |
|
$222.34M |
|
$162.46M |
|
$2.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
121.97 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.00 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.78% |
|
-0.78% |
|
-0.77% |
|
-0.78% |
|
$22.54 |
|
$-1.72 |
|
$-1.72 |
|